poster presentation list for ilc2016 - ciccstciccst.org.cn/ilc2016/poster.pdf · abstract no. title...

Abstract No. Title

ILC1.1-001 Effect of Capacity Building in Leprosy for Medical Officers

ILC1.1-002 Reliability of lesion counting system for classification of multibacillary leprosy

ILC1.1-003 Contact tracing of new leprosy patients with high Bacillary Index (4 and above) from Allahabad district, Northern India

ILC1.1-004 Urbanization and Leprosy: Situation analysis in Dhaka City Corporation Area, Bangladesh

ILC1.1-005 Situation Analysis of Leprosy burden in selected Tea Garden of Moulovibazar district, Bangladesh

ILC1.1-006 Costing of Tertiary Level Leprosy Clinical Services

ILC1.1-007Emphasizing the relevance of Specialized Leprosy Centres: 11 year trend of admissions for Leprosy Complications at a Tertiary Leprosy Referral Centre in

North India

ILC1.1-008 Concept Paper: Health Management System of The Leprosy Mission Trust India as a Prototype for Central Leprosy Database for Surveillance of Leprosy

ILC1.1-009 Validating the benchmark costs of 2013: FAIRMED’s experience of supporting leprosy tertiary care hospitals in India

ILC1.1-010 TREATMENT OF LEPROSY NEUROPATHIES

ILC1.1-011 Identification of Mycobacteria species from trophic ulcers of leprosy patients

ILC1.1-012 ILC I CLINICAL SCIENCE

ILC1.1-013 Drug Sensitivity and the Changing Patterns of Bacterial Isolates of Infected Ulcers of Leprosy Patients in Central Leprosy Institute-Retrospective Analysis

ILC1.1-014 Improving Quality of Care using Mobile Technology: Experiences from Urban Leprosy Project in Kolkata, India

ILC1.1-015 Quality Of Life In Paucibacillary And Multibacillary Leprosy Patients: A Comparative Analysis

ILC1.1-016 Multibacillary Leprosy: Dietary and Nutritional Surveillance, An Experience In Brazil

ILC1.1-018 Is ―access denied‖ a cause of disability due to Leprosy in Sri Lanka?

POSTER PRESENTATION LIST FOR ILC2016

Abstract No. Title


ILC1.1-019 Evaluation of Drug Use Pattern in Central Leprosy Teaching and Research Institute as a Tool to Promote Rational Prescribing

ILC1.1-020 The use of nerve ultrasound as a diagnostic test for leprosy

ILC1.1-021Analysis of Problems on Applying ICD-10 Coding Rules to the Medical History Management of the Hansen’s Disease Patients/Ex-patients and Proposal of the

Revision

ILC1.1-025 Parasitic Co-infection in Patients with Hansen’s disease Attended at the Eduardo de Menezes Hospital, Minas Gerais, Brazil

ILC1.1-026 Performance of the Multidisciplinary Team in the Treatment of Plantar Ulcer in a Patient with Hansen’s Disease

ILC1.1-027 Case Report: Leprosy Macular Reaction

ILC1.1-028 The Importance of Multidisciplinary Care in Monitoring Patients with Leprosy and Prevention of Disabilities

ILC1.1-029 Lucio’s Phenomenon with Extensive Ulcerations Progressing to Death: Case Report and Literature Review

ILC1.1-030 Case report: Necrotic Erythema Nodosum Leprosum

ILC1.1-031 Impact of one month training in leprosy on Physiotherapy graduates

ILC1.1-032 A field report: why do people affected by leprosy migrate to Delhi for treatment?

ILC1.1-034 20 years of Leprosy in the United Kingdom - where do the diagnostic delays occur?

ILC1.1-035 Case Report of Two Cases of Fever, Rash, and Organ Involvement during the Treatment of Leprosy

ILC1.1-036 Screening for Diabetes in a Leprosy Hospital

ILC1.1-037 Role of medical officer in a leprosy focused hospital: an experience

ILC1.1-039 Are leprosy focused hospital are the hospital for diagnosis of non-leprosy related problems for person affected by leprosy: Trends in last five years(2011-2015)

ILC1.1-040 Detection of Thermal Thresholds in Skin Lesions - New Cases of Patients with Hansen's Disease

Abstract No. Title


ILC1.1-041 Case Analysis of New and Recurrent Leprosy in Xuancheng During 2006 to 2012

ILC1.1-042 Spectrum of leprosy: A study to evaluate the various classification criteria

ILC1.1-043 An investigation on the prosthetic status in patients with leprosy

ILC1.1-044 Therapeutic dilemma of refractory erythema nodosum leprosum: A case report

ILC1.1-045 Analysis of Dyslipidemia in Lepers

ILC1.1-046 A case of leprosy aggregated in family

ILC1.1-047 A case of leprosy

ILC1.1-048 Leprosy knowledge among the students of RCI (Rehabilitation Council of India) courses

ILC1.1-049 The effective evaluation of the vacuum sealing drainage dressing in leprosy ulcers

ILC1.1-053 Misdiagnosis Analysis of Leprosy Cases from 2011 to 2015 in Ganzhou

ILC1.1-055 The clinical analysis of 712 newly detected leprosy cases

ILC1.1-056 The Misdiagnosis Analysis of 3 Cases of Type BL Leprosy

ILC1.1-058 A report on a patient of lepra lepromatosa( LL) twice misdiagnosed lymphoma by two big hospital

ILC1.1-059 Diagnosis methods of leprosy

ILC1.1-060 Nodular Lepromatous Leprosy Mimicking Prurigo Nodularis

ILC1.2-002 U-MDT; are we ready for the change: a retrospective study on clinical non-responsiveness to MDT in multibacillary patients

ILC1.2-003 Experiences with Thalidomide for Erythema Nodosum Leprosum – a retrospective study

Abstract No. Title


ILC1.2-004 COMPARATIVE EVALUATION OF A NEW 1,3-DIAZINON-4 PYaTd1 AND DAPSONE ON PERIPHERAL BLOOD INDICATORS IN THE EXPERIMENT

ILC1.2-006 Treatment Completion and Adverse Effect Profile of Multi Drug Therapy for Leprosy in Sri Lanka

ILC1.2-008 Treatment of Trophic Ulcers in Leprosy with Intralesional Autologous Platelet Rich Plasma

ILC1.2-011 Any chemical treatment progress

ILC1.2-012 Topical Application of Platelet Rich Plasma in Treatment Chronic Leprosy Leg Ulcer

ILC1.2-014 RELAPSES IN LEPROSY – FIELD AND CLINICAL OBSERVATIONS

ILC1.2-015 Results of eight years’ following up among multibacillary patients treated with six months of UMDT in China

ILC1.2-016 Analysis of Combined Chemotherapy towards Leprosy in Hezhou, Guangxi

ILC1.2-017 A Case of Misdiagnosed Multidiscipline Leprosy

ILC1.2-018 Misdiagnosis of leprosy report of two cases

ILC1.2-019 A three generations of lineal consanguinity 4 people with leprosy with DDS syndrome in children 1 case report

ILC1.2-020 Experimental treatment for Jorge Lobo’s disease with MDT/MB/WHO

ILC1.2-021 Comparative Study between Multi Drug and Homoeopathic Medicine in Treatment of Multibacillary Leprosy

ILC1.2-022 Drug-resistance surveillance and genotyping of Mycobacterium leprae strains from Yemen

ILC1.2-023 Transmission of drug-resistant leprosy in Guinea-Conakry detected by molecular epidemiological approaches

ILC1.2-026 Immunology confirmation of Dapsone Hypersistivity Syndrome -- preliminary report

ILC1.3-005 Metformin, an antidiabetic drug as a therapeutic agent in the management of chronic recurrent moderate to severe Erythema Nodosum Leprosum.

Abstract No. Title


ILC1.3-007 Targeting mental stressors for the prevention of recurrence of lepra reactions.

ILC1.3-008 Mycobacterium Leprae, Helminths, Micronutrient Deficiencies and Reactions: Elucidating Risk Factors For Hansen’s Disease Associated Morbidity

ILC1.3-009 Necrotic erythema nodosum leprosum: an emergency in Leprosy –report of two cases

ILC1.3-014 Erythema Nodosum Leprosum (ENL) and Pregnancy: A Report of Three Cases

ILC1.3-016 The Impact of Erythema Nodosum Leprosum on Health Related Quality of Life in Rio de Janeiro, Brazil– an ENLIST Group study

ILC1.3-018 The Effect of Erythema Nodosum Leprosum on Health Related Quality of Life in People with Multibacillary Leprosy in Bangladesh – an ENLIST Group Study

ILC1.3-019 Deep Vein Thrombosis Diagnosticated in a Patient with Erythema NodosumLeprosum in use of Thalidomide and Corticosteroids: a Case Report

ILC1.3-020 Bilateral Deep Vein Thrombosis Diagnosticated in a Patient with Erythema Nodosum Leprosum and Leishmaniasis in use of Thalidomide and Corticosteroids

ILC1.3-022 A review on primary neuritic leprosy

ILC1.3-025 LENALIDOMIDE IN ENL REACTIONS IN LEPROSY – PRELIMINARY OBSERVATIONS

ILC1.3-028 SEVERE REVERSAL REACTION IN A KIDNEY TRANSPLANT RECIPIENT: A PARADOX MEDIATED BY REGULATORY T-CELLS (Tregs)?

ILC1.3-033 Lucio Phenomenon in Child with Cushing Syndrome Successfully Treated with Pentoxifylline: a Case Report

ILC1.4-001 Clinico-Pathological Features of Erythema Nodosum Leprosum: A case-control Study at ALERT Hospital, Ethiopia.

ILC1.4-002 PRESENCE OF M. LEPRAE IN THE SPUTUM OF A PATIENT WITH RESPIRATORY SYMPTOMS IN BEL?M, PAR? STATE, BRAZIL.

ILC1.4-003 Evaluation of Patients With Relapsed Leprosy After Multidrug Treatment at a Leprosy Clinic in Rio de Janeiro, Brazil.

ILC1.4-005 Cutaneous sarcoidosis with granuloma formation around nerves mimicking mycobacterial infection

ILC1.4-006 Think Of Leprosy, Even In The Era Of Elimination

Abstract No. Title


ILC1.4-007 Two cases of leprosy in siblings caused by Mycobacterium lepromatosis

ILC1.4-008 Erythroderma as a manifestation of borderline tuberculoid leprosy on reversal reaction: report of a case

ILC1.4-009 The Analysis of 8 cases of numb erythema

ILC1.4-011 Lepromatous leprosy and neurofibromatosis: two cases of association and one misdiagnosis

ILC1.4-012 Clinical Research of PHN Treated by Pricking and Cupping Combined with Nourishing Yin and Activating Blood Circulation

ILC1.4-013 Clinical Observation of Vitiligo Treated by 308nm Excimer Laser Combined with Vernonia Anthelmintica Willd Injection in Points

ILC1.4-014 Observation of the Clinical Effects on Herpes Zoster Treated by Penciclovir

ILC1.4-015 The Curative Observation of 42 Cases of Pityriasis Rosea Treated by Narrow-band UltravileB

ILC1.4-016 A Case of Acute Generalized Exanthematous Pustulosis

ILC1.4-017 Tacrolimus ointment combined with NB-UVB treatment of facial seborrheic dermatitis clinical curative effect

ILC1.4-018 Clinical Observation of Chloasma Treated by Liuwei Dihuang Pills and Xiaoyao Pills Combined with Alpha Hydroxy Acids

ILC1.4-019 Clinical Observation of Pityriasis Rosea Treated by Compound Glycyrrhizin Combined with Narrow-band UltravileB

ILC1.4-020Effect observation of traditional chinese medicine syndrome differentiation and treatment combined with excimer light 308 nm in the treatment of psoriasis

vulgaris

ILC1.4-021 The clinical observation of pricking and cupping therapy combining with chinese herbs for Qi stagnation and blood stasis type of postherpetic neuralgia

ILC1.4-022 A pocrine hidrocystoma with intradermal nevus:a case report

ILC1.4-023Effectiveness of oral low-dose dapsone therapy for generalized acquired cutis laxa associated with IgA-lambda monoclonal gammopathy and urticarial

neutrophilic dermatosis

ILC1.4-024 Retrospective analysis of clinical characteristics of 59 cases of nonmelanoma skin cancers of the scalp

Abstract No. Title


ILC1.4-025 A Case of Metastatic Adenocarcinoma of the Uterine Cervix Mimicking Eczema

ILC1.4-026 In vitro experimental study of CXCR7-shRNA's targeted inhibition on melanoma M14 cell line

ILC1.4-027 Clinical Observation of Traditional Chinese Medicine Mask Combination with Cold Spray on Facial Corticosteroid Dependent Dermatitis

ILC1.4-028 The Curative Effect of Eupolyphaga Particles Combined with Acyclovir in the treatment of Herpes Zoster

ILC1.4-029 Discussion of Curative Effects on Allergic Dermatitis Treated by Combined Therapy of Chinese and Western Medicine

ILC1.4-030 Observation of Clinical Curative Effects on Postherpetic Neuralgia Treated by Mouse Nerve Growth Factor

ILC1.4-031 Discussion of effects on Psoriasis treated by traditional Chinese medicine of cooling and activating blood circulation formula

ILC1.4-032 Observation of Clinical Curative Effects on Psoriasis Vulgaris Treated by Xiyanping Injections Combined with Tripterysium Glycosides

ILC1.4-033 The clinical study of early antiviral drugs combined with herb fumigation and phototherapy in the preservation of postherpetic neuralgia

ILC1.4-035 Experimental treatment for Jorge Lobo’s disease with MDT/MB/WHO

ILC1.4-037 Lucio Leprosy with Lucio Phenomenon and Secondary Cryoglobulinemia in One of the Twin Brothers Leprosy Patients: a Case Report

ILC1.4-038 A Clinical observation about Mizolastine combine with ranitidine to treat chronic idiopathic urticaria

ILC1.4-039 The expression and significance of brain—derived neurotrophic factor in plasma of patients with psoriasis vulgaris

ILC1.5-001 Patients' experience after Tarsorraphy procedure of the eye

ILC1.5-002 The Visual Acuity Change of Clinically Cured Leprosy Patients in National Sanatorium Oku-komyoen in Japan over a period of 20 years.

ILC2.2-004 Begotten of Corruption? Tracing the history of stigma for people with leprosy in South Asia

ILC2.2-009 From Dignity to Advocacy

Abstract No. Title


ILC2.2-011 Sterilization in Leprosy Control & Public Interest Litigation in Korea

ILC2.2-012CROSS-CULTURAL ADAPTATION OF THE EXPLANATORY MODEL INTERVIEW CATALOGUE STIGMA SCALE FOR LEPROSY AFFECTED PEOPLE IN

BRAZIL

ILC2.2-013 Gender differentials in patients reporting late for leprosy treatment in an urban centre in North India

ILC2.2-016 Timeline of Human Rights and Leprosy from the perspective of public health policies in Brazil

ILC2.2-017The Empowerment of People Affected by Leprosy through Making Biogas to Increase Productivity and Eliminate the Discrimination of People Affected by

Leprosy in Sumberglagah, Indonesia by LCC Indonesia

ILC2.2-021 Analysis of Individual Survey on the Cured Leprosy Survivor in Hezhou City of Guangxi Province

ILC2.2-022 Analysis of alimony subsidy level of people infected by leprosy live in leprosy villages in Guangdong province, China

ILC2.2-023 An analysis of 230 cases of people affected by leprosy control services for the satisfaction of conditions

ILC2.3-001 Children and Adolescents attitude towards having Leprosy in an High Endemic District of Eastern India

ILC2.3-003Long Term Social Welfare Activities Undertaken by Leprosy Patients Welfare Society (LPWS) with an Aim to Provide Respectable Socio-Economic

Rehabilitation to Destitute and Disabled Leprosy Patients

ILC2.3-004Effectiveness of the Orientation Training for Laboratory Technicians in leprosy Skin Smear and Nasal Smear Techniques in central leprosy teaching and

research institute. India

ILC2.3-006 Self esteem of the adolescents from leprosy affected families

ILC2.3-007 Innovative strategies to cope with stress patients admitted with recurrent Lepra reactions.

ILC2.3-008 Perception and attitude of the admitted chronic ulcer patients towards self-care and leprosy as a disease

ILC2.3-009 Practical difficulties faced during follow up of defaulters patients registered for MDT in urban clinical set up.

ILC2.3-014 Behaviour Change Communication in Leprosy – Understanding the Needs of Indigenous Population

ILC2.3-016 Parental attitudes and their infuence on the management of leprosy affected children

Abstract No. Title


ILC2.3-021 Level of Perceived stigma and its psycho-social implications among leprosy affected individuals living in rural communities of Western Maharashtra

ILC2.3-024 Impact of Micro Credit System on quality of life of Leprosy Affected Members of Self Help Groups in Maharashtra, India.

ILC2.3-025 Assessment of physical and Socio – Economic Needs of People Affected by Leprosy in Kanchanaburi province ,Thailand

ILC2.3-026 IMPACT OF TRANSFORMING AN EXCLUSIVE LEPROSY HOSPITAL INTO A LEPROSY FOCUSED COMMUNITY (GENERAL) HOSPITAL

ILC2.3-027 REBUILDING THE LIVES OF PEOPLE AFFECTED WITH LEPROSY IN A COLLABORATIVE APPROACH – AN EXPERIENCE

ILC2.3-028 Development and Validation of a Questionnaire to measure attitudes of health care providers towards leprosy

ILC2.3-030 Perceptions of informal healthcare providers towards the National Leprosy Eradication Programme in India

ILC2.3-032 Cultural validation of a new leprosy related stigma measurement: SARI Stigma Scale

ILC2.3-035 Impact Of The Earthquake On Overall Well Being Of People Affected By Leprosy

ILC2.3-036 The implications of climate change on leprosy and leprosy affected people

ILC2.3-037 Title : PROFILE OF STIGMA AFTER CONTROL AND ELIMINATION OF LEPROSY IN INDIA

ILC2.3-038 Impact of Socio-economic Rehabilitation program of The Leprosy Mission Trust India on People Affected by Leprosy from Northern India

ILC2.3-039 Leprosy Post-Exposure Prophylaxis and Perception of Leprosy

ILC2.3-040 Models for building sustainable livelihood for the leprosy affected and marginalized people

ILC2.3-041 Three Box Solution to the socio-psychological problems of leprosy patients

ILC2.3-047 The Attitudes of Village member towards leprosy and relatives in Pho si suwan District, Sisaket Province, 2015.

ILC2.3-048 Quel avenir pour les handicapés de la lèpre après atteinte du seuil de son élimination : Cas du Cameroun.

Abstract No. Title


ILC2.3-049 Investigation into leprosy rehabilitation villages in Guangyuan

ILC2.3-051 184 cases of leprosy mental state analysis

ILC2.3-053 Investigation and analysis of the present functioning situation of leprosy villages in Jiangsu Province

ILC2.3-055 role of print media in covering leprosy related news

ILC2.3-056 Direction of Health Education of County-Level Prevention and Control Institution of Leprosy

ILC2.3-057 Investigation and analysis on the core knowledge about leprosy control of urban and rural residents in Jiangsu Province

ILC2.3-062 A study of the effect of floods on the lives of the leprosy affected in Cuddalore District, Tamil Nadu , India

ILC2.3-063 SOCIO ECONOMIC STATUS OF YOUNG YOUTHS AFTER VOCATIONAL TRAINING PROGRAMMEIN TLM VADATHORASALUR, TAMILNADU

ILC2.3-064 QUALITATIVE ANALYSIS OF THE FACTORS ASSOCIATED WITH DEHABILITATION OF LEPROSY AFFECTED

ILC2.3-065 Leprosy perception among Self Help Group members in Rautahat District, Nepal

ILC2.3-066A socio-economic survey among leprosy and other disabled populations prior to launch of community-based rehabilitation within a rural central Nepal

population

ILC2.3-067 Psychological well-being and experiences of disabled leprosy-affected persons following the devastating 2015 earthquake in Nepal

ILC2.4-004 Changes in Social participation and disability level among leprosy affected persons before and after completion of multidrug therapy

ILC2.4-005 Fair labour practices of people affected by leprosy and disability, working with wage and self employed

ILC2.4-006 Participation Restriction of People Affected by Leprosy in South Sudan

ILC2.4-008 Engaging people affected by leprosy as research partners in qualitative research

ILC2.4-011 Abstract: Participation Restriction of People Affected by Leprosy in South Sudan (Revised and Edited version)

Abstract No. Title


ILC2.4-013A HOLISTIC REHABILITATION PROGRAM FOR LEPROSY AFFLICTED PEOPLE: A SEVEN-DECADE EXPERIENCE FROM A CENTER IN CENTRAL

INDIA

ILC2.4-014 Community Participation in Leprosy Care Through Integrated Health Care: A Dream Come True

ILC2.4-015 Transformation of Life of People Living In Leprosy Colonies with the Chetana Intervention

ILC2.4-018 ―Integrated Protective Footwear unit at District level: Footwear for all‖

ILC2.4-019The knowledge, Attitude and Practice of Health Workers towards Leprosy at Kokosa Woreda Health Centers and Clinic, West Arsi zone, Oromia Regional

State, Ethiopia

ILC2.4-020 Development Evaluation: The Art of Nudge Leprosy Elimination Project in 12th Health Area, Lower South Thailand

ILC2.4-022 Ten Top Tips for Including People Affected by Leprosy and Disability in Mainstream Development Programmes – Learning from Bangladesh

ILC2.4-023 CBR groups improve leprosy case finding in Kongo Central province, DRC

ILC2.4-025 The Role of IDEA Nepal in Eradication of the Disease as well as its Consequences; disability and discrimination

ILC2.4-031 Introduction to regional leprosy prevention center logistics management

ILC2.4-032 Investigation of Leprosy Core Knowledge and Awareness in Weiyuan County

ILC2.4-033 Increasing awareness to exclude social exclusion in Angola

ILC2.4-034 Participation Of Local Cooperatives/Self help group Members In Disaster Response To Reduce Stigma And Enhance Community Participation

ILC3.1-001 Live Mycobacterium leprae preferentially prime regulatory T cell responses associated with the development of lepromatous leprosy

ILC3.1-002 Immunological Observation of the Role of T Helper 17 Cells in Lucio's Phenomenon

ILC3.1-003 Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review

ILC3.1-005 New Insight into the Pathogenesis of Erythema Nodosum Leprosum: Is there a Role of Activated Memory T-cells?

Abstract No. Title


ILC3.1-008 Inflammatory Mediators in Periodontal Diseases and Leprosy Reactions

ILC3.1-009 Association of Localized Expression of Cathelicidin and Vitamin D Receptor in Type 1 Reaction of Leprosy Patients

ILC3.1-010 T cell Epitope Mimicry between Host Keratin and proteins of M. leprae

ILC3.1-014 Immunological response to Mycobacterium leprae: potential application for leprosy diagnosis

ILC3.1-015 Regulatory B cells in patients with leprosy and in household contacts

ILC3.1-018 Immunohistochemical Assessment of the Cell Populations in Leprosy-Spectrum Lesions and Reactional Forms

ILC3.1-019 Phenotypic Characterization of Immunoregulation Mechanisms of Tregs Cells in the Polar Forms of Leprosy: Emphasis on Cell Apoptosis Pathway

ILC3.1-020 Characteristics of the Immune Regulation of Skin in Leprosy Patients

ILC3.1-021 Salivary antibody response in leprosy patients and their household contacts

ILC3.1-023Mycobacterial R32-Kda Ag Specific T Cell Responses Correlate with Successful Treatment and Heightened Antimicrobial Response in Human Leprosy

Patients

ILC3.1-025Evaluation of the Immune Response in Erythema Nodosum Leprosum: Quantification and Expression of Cytokines and Analyses of the Reactive Oxygen and

Nitrogen Intermediates.

ILC3.1-028The Profile of Proliferation Index of Lymphocyte and Th1 / Th 2 as Lymphocyte Response in Reversal Reaction State Leprosy After Exposure to Dharmendra

Antigen

ILC3.1-029 Evaluation of sensitivity and specificity and its clinical application value of ND-O-BSA-IgM-ELISA in detection of leprosy

ILC3.1-030 Detection of PGL-1 antibody in the lepers

ILC3.1-031 Evaluation of two synthetic antigens in the diagnosis of leprosy

ILC3.1-032 The Expression of Chemokine Recpetor CXCR4 of Leprosy and Human Immunodeficiency Virus-1 Co-infected Subjects

ILC3.1-033 Field Evaluation of Assays to Detect Cellular and Humoral ImmuneResponses for Early Diagnosis of Leprosy

Abstract No. Title


ILC3.1-034 Does leprosy have the infection immunity as tuberculosis?

ILC3.1-035 Preliminary study of Ppar-gamma and ADRP with leprosy host lipid metabolism and the immune

ILC3.1-036 A Preliminary Study on Specificity of Whole M. leprae and Its Some Antigens

ILC3.1-037Detection of antibodies to M. leprae NDO, LID-1 and MMP-II to recognize leprosy patients and the leprosy high-risk population of household contacts in Yunnan

province

ILC3.1-039 Active search of leprosy cases among school children with positive serology using a rapid test in an endemic area of Brazil

ILC3.1-040 THE PROFILE OF ANTI PGL-1 ANTIBODY AMONG CHILDREN TB PATIENTS

ILC3.2-001INCREASING ANTIMYCOBACTERIAL ACTIVITY OF SYNTHETIC DRUGS UNDER THE INFLUENCE OF SUBSTANCES OF PLANT ORIGIN IN THE

EXPERIMENT

ILC3.2-002 Characterization of Mycobacterium leprae Diguanylate Cyclases

ILC3.2-003THE SEARCH FOR NEW COMPOUNDS WITH ANTI-MYCOBACTERIAL ACTIVITY AMONG DERIVATIVES OF 1,3 -DIAZINON-4 AND THEIR ACYCLIC

PREDECESSORS

ILC3.2-006 Characterization of pre-rRNA as a viability indicator for Mycobacterium leprae

ILC3.2-007 Nitazoxanide is active against Mycobacterium leprae in vitro

ILC3.2-008 Role of Mouse Foot Pad Inoculation Study to Diagnose Leprosy Relapse and to Determine Drug Resistance to WHO MDT.

ILC3.2-011 A unique mutation on folP1 in Mycobacterium lepromatosis detected from leprosy patients in Mexico

ILC3.2-012 Human Organotypic Skin Explant Culture to Cultive of Mycobacterium leprae

ILC3.2-013 Up-regulation of mir-5703 expression under sonicates of M. leprae challenge in multibacillary leprosy patients: a preliminary study

ILC3.2-014 GEOGRAPHICAL DISTRIBUTION OF Mycobacterium leprae spp. IN INDONESIA BASED ON THE TTC REPEATS

ILC3.3-003 Genetic research of leprosy

Abstract No. Title


ILC3.3-004 A Genome-wide Meta-analysis of leprosy Identifies Four Novel leprosy Susceptibility Loci in Chinese

ILC3.3-006 Multidrug Resistance among Mycobacterium leprae strains from Indian Relapsed Leprosy Patients

ILC3.3-007 In-Silico Approach for Screening of Interaction of rpoB gene to Secondary-Line Anti- Leprosy Drugs for Rifampicin Resistant M. leprae

ILC3.3-008 Tuberculosis risk-associated SNPs do not show association with leprosy in Chinese population

ILC3.3-011 Understanding transmission of leprosy in an endemic region of India using molecular typing of Mycobacterium leprae.

ILC3.3-012 ―A study on viable Mycobacterium leprae by 16S rRNA and transcriptome analysis of soil of an endemic region in India‖

ILC3.3-013 Fine mapping and functional analyses confirm a SNP within gene LACC1 to be a susceptibility locus for leprosy pathogenesis in Chinese population

ILC3.3-014 VIABILITY OF MYCOBACTERIUM LEPRAE IN RFT (RELEASE FROM TREATMENT) PATIENTS; TIME TO REDESIGN THE REGIMEN SCENARIO

ILC3.3-015 Role of Toll-like Receptor Polymorphism in Determining Host Susceptibility for Leprosy: Epidemiological Study in Purulia District of West Bengal, India

ILC3.3-016 PCR amplification of genomic Mycobacterium leprae DNA by using different gene targets

ILC3.3-018 Emergence of Rifampicin drug resistant M.leprae in Kolkata region of West Bengal.

ILC3.3-019 ROLE OF AUTOIMMUNITY IN NERVE DAMAGE; MOLECULAR MIMICRY OF M.LEPRAE TO MULTPLE NERVE PROTEIN REGIONS

ILC3.3-020 Application of Polymerase Chain Reaction (PCR) in The Genome of Mycobacterium leprae Detection and Diagnosis of Leprosy

ILC3.3-021 Expression of microRNAs in Skin Lesions of Leprosy

ILC3.3-022 Association of CCL 2 Variants (-2518A>G and -362G>C) with Leprosy in a Population of Northern Indian States- An Exploration

ILC3.3-023Rifampicin Resistant Leprosy in Southern India; Analysis of Efflux Pump Gene Expressions and Molecular Modelling of Rifampicin–RpoB interactions in

Mycobacterium leprae.

ILC3.3-024 Genotyping (SNPs) of Mycobacterium leprae of leprosy patients from Sanatorium Fontilles, Spain.

Abstract No. Title


ILC3.3-025Real Time-PCR and High Resolution Melting Analysis for Drug Susceptibility Testing of Mycobacterium leprae Directly from Clinical Specimens of Leprosy

Patients

ILC3.3-026 Association of CCL 2 Variants (rs1024611 and rs 2857656) with Leprosy in a Population of Northern Indian States- An Exploration

ILC3.3-027 The Transcriptome of Mycobacterium leprae During Growth in Mouse Foot Pad

ILC3.3-030 Genotyping of Mycobacterium leprae in Guangdong province

ILC3.3-031 Association between genetic variants in TNFSF15 gene and leprosy among the Chinese Yi population

ILC4.1-001 Prevalence and Severity of Late Disability due to Leprosy in Bangladesh with Key Characteristics of Disabled People

ILC4.1-002 An epidemiology of leprosy among children of high prevalent districts of West Bengal.

ILC4.1-004 Leprosy in the Kimberley region of Australia; historical context and current challenges

ILC4.1-005 Changing Profile of Leprosy from an Endemic Area in Allahabad district, Uttar Pradesh, India

ILC4.1-006 Health Seeking Behavior of New Adult Leprosy patients from an Endemic Area in Allahabad district, Uttar Pradesh, India

ILC4.1-010 ADVANCING LEPROSY ERADICATION

ILC4.1-012 Leprosy in Russia

ILC4.1-013Serological monitoring of levels of immunoglobulin M to a specific semi-synthetic ANTIGEN M.LEPRAE in residents of endemic and non-endemic leprosy

RUSSIAN REGIONS

ILC4.1-014Stratification of new Leprosy cases notified in Mile 4 hospital, Ebonyi state, Nigeria in 2014 by residential addresses: implication for mapping leprosy cases in

countries with leprosy endemicity.

ILC4.1-015 Forecasting New Case Detection Rates of Leprosy: A Survey of Experts

ILC4.1-016 Risk factors for treatment default among multibacillary leprosy patients

ILC4.1-017 Risk factors for treatment default among multibacillary leprosy patients treated with the Multiple Drug Therapy

Abstract No. Title


ILC4.1-019 Android based software for field data collection for Leprosy in India

ILC4.1-020 Sex Differences in the Epidemiological Profile and Treatment Outcomes of Leprosy Patients in a Rural Hospital in South-Eastern Nigeria

ILC4.1-022 Characterization of leprosy contacts in a Brazilian endemic municipality during 2013 to 2014.

ILC4.1-023 An 1-Year Study of Leprosy Cases Diagnosed at Eduardo de Menezes Hospital, Minas Gerais State, Brazil

ILC4.1-024 Trends of leprosy at leprosy referral hospital in high endemic district Purulia, West Bengal, India.

ILC4.1-026 A Profile with resistance pattern among relapsed patients at The Leprosy Mission Hospital, Purulia.

ILC4.1-027 Trends of New Leprosy patients accessing Tertiary Leprosy Referral Hospitals in India

ILC4.1-028 LEPROSY PATIENTS ATTENDED AT A UNIVERSITY HOSPITAL IN NORTHEAST BRAZIL: CLINICAL AND EPIDEMIOLOGICAL, 2007-2011

ILC4.1-029 Oral health status, access to dental health services and self-perceived oral health in patients with leprosy in a hyper-endemic area of the Brazilian Amazon

ILC4.1-030 Leprosy in Israel: a non-endemic, immigrant-rich country

ILC4.1-031 Household contact surveillance in a hyper-endemic municipality of the Brazilian Amazon region: the user?s perspective

ILC4.1-032A FAMILY-BASED STRATEGY TO ENHANCE CONTACT-TRACING PROGRAMMES IN BRAZIL: THE EXPERIENCE FROM BAHIA STATE, NORTHEAST

REGION

ILC4.1-034 Clinical Variables Associated with Worsening of Disability Grade in Leprosy Cases during Treatment in South-Eastern Nigeria

ILC4.1-035 The trend forecast of the prevalence of leprosy in Gansu province

ILC4.1-036 Epidemiological Analyses of Leprosy in Children in Anhui from 1949 to 2013

ILC4.1-037 Epidemiological Analysis of Leprosy in Low Epidemic Situation in Hanchuan

ILC4.1-039 Epidemiological Analyses of Leprosy in new cases

Abstract No. Title


ILC4.1-040 Epidemiological analysis on new cases of leprosy in Bozhou city between 1993 and 2012

ILC4.1-041 Analysis of new cases of leprosy in Hubei Province in 2006-2015

ILC4.1-042 Epidemiology Analysis of the Leprosy Endemic Status from 1935 to 2015 in Henan Province

ILC4.1-043 Epidemiological analysis on leprosy in Sichuan, China, 2000-2014

ILC4.1-044 The epidemiological of analysis on leprosy in Xi’an city from 1986 to 2015

ILC4.1-045 ACCESS TO DIAGNOSIS OF CHILDREN UNDER 15 YEARS OLD WITH LEPROSY

ILC4.1-046 Search for Mycobacterium leprae in Amazonic armadillos in a hyper endemic location

ILC4.1-047 Investigate of the health status of cured leprosy patients in Zhejiang province

ILC4.1-048 Investigation on living situation of cured patients with leprosy in Zhejiang province

ILC4.1-050 The analysis of the disability situation among new leprosy cases in Dazhou, Sichuan

ILC4.1-051 Survey on the awareness status of key message on leprosy control among national public in epidemic area in 2012

ILC4.1-052 Investigation on Quality of Life in Cured Patients with Leprosy

ILC4.1-053 Study on the mental disorder among leprosy affected persons and the its influencing factors

ILC4.1-054 THE PROFILE OF ANTI PGL-1 ANTIBODY AMONG CHILDREN TB PATIENTS

ILC4.1-056 Profile of New detected Patients with Grade 2 disabilities from non endemic areas in Maharashtra state in India

ILC4.1-057 Analysis of the epidemic situation after basic elimination of leprosy in Lianyungang prefecture for 18 years

ILC4.1-058To access the importance of inclusion of Grade 2 Disability (G2D) among Children in the Routine Reporting system – Experience from a pilot study in two

districts in state of Bihar, India

Abstract No. Title


ILC4.1-059 Investigation on Quality of Life in Cured Patients with Leprosy in WenZhou, Zhejiang Province

ILC4.1-060 Epidemiological Analysis of New Leprosy Cases Detected in Beijing From 1990–2013

ILC4.1-061 Advances on the research of influencing factors of quality of life among leprosy affected persons

ILC4.1-062 The Epidemiology Analysis Report of Leprosy

ILC4.1-063 Epidemiology and treatment of tinea capitis in Nanchang and surrounding area

ILC4.1-064 Epidemiological analysis on 928 leprosy cases registered from 1994 to 2013 in Jiangsu province

ILC4.1-065 Epidemiological Analysis on New (recurrence) leprosy cases of Xuzhou during 1994-2013

ILC4.1-066 Evaluation of Yunnan leprosy control work in last 60 years

ILC4.1-067 18 years of longitudinal follow-up post leprosy elimination in 43 counties in Yunnan province- An epidemiological report

ILC4.1-068 Analysis on the epidemiological characteristics of leprosy in Yunnan Province in 2010

ILC4.1-069 Yunnan leprosy training needs analysis

ILC4.1-070 Irregular remaining 2354 examples of Yunnan Province Zhao Tong City lepriasis investigation is analytical

ILC4.1-071 Discuss the leprosy patients’ detection method under the situation of Low prevalence

ILC4.1-073 Leprosy profile through the post-leprosy elimination era: Epidemiology and clinical characteristic of diseases from a tertiary care hospital

ILC4.1-075 Analysis of Epidemic situation of leprosy in Hunan province during 1993-2012

ILC4.2-001 Leprosy Outreach: An Effective Tool for Early Case Detection in a High Prevalent District Bardiya, Nepal

ILC4.2-005 Genogram application in families with leprosy cases in eastern of Minas Gerais Brazil for assist in socio-demographic and clinical characterization.

Abstract No. Title


ILC4.2-007 Trends of slit skin smear cases in positivity among new leprosy cases reported in The Leprosy Mission hospitalShahdara Delhi.

ILC4.2-009 Profile of Leprosy among Children attending a Referral Hospital for Leprosy in Northern India

ILC4.2-012 Trends in Leprosy Diagnosis during Pre-And Post-Elimination at an Outpatient Referral Clinic

ILC4.2-014 Significance of Referral Centres in Rendering Quality Services in Leprosy

ILC4.2-015 Role of Local Stakeholders in Enhancing Leprosy Case Detection in Tribal Areas

ILC4.2-016 ROM TREATED CASES FOR SINGLE SKIN LESION LEPROSY IN SOUTHERN INDIA: A 12 YEAR FOLLOW-UP STUDY

ILC4.2-019 The results of the clinical examination population of the Republic of Karakalpakstan on Hansen disease

ILC4.2-020 The Survey on Self-examination Behavior among Leprosy’s contact at high risk area in Thailand,2015.

ILC4.2-021 Model development of referral system for leprosy patients and enhancement of quality of leprosy control under low endemic condition, Surin province

ILC4.2-022 Factor of Delayed Diagnosis and Treatment in Leprosy at health region 9

ILC4.2-023 Data Quality Audit (DQA) of FAIRMED supported leprosy hospitals in India

ILC4.2-024 How Big or Small Leprosy in Bangladesh: A Country Situation Analysis, Epidemiology, Programme and Policy Implications

ILC4.2-027 Leprosy, Elimination and Continuing Challenges in Nepal

ILC4.2-028 Risk Factors Associated with Delayed Diagnosis of Leprosy in Maharashtra, India

ILC4.2-031 Appraisal of Epidemiological Risk Areas and Effects of Leprosy Detection Interventions: Evidence from Leprosy Elimination Project, Deep South of Thailand

ILC4.2-032 Comprehensive District Leprosy Control Program (CDLCP): Combining FAIRMED’s (FM) tertiary hospital services with field-based services in India

ILC4.2-033 Reaching to unreached people – Mobile Information, Education, Communication Van in Bihar, India

Abstract No. Title


ILC4.2-035 8 year Trend in proportion of Grade 2 disability among new leprosy cases in Nigeria (2007 - 2014): lessons learnt

ILC4.2-036Active case-finding for intensifying leprosy elimination in 8 Provinces of the Democratic Republic of the Congo and achieve the Bangkok Declaration of July

2013

ILC4.2-042Epidemiology and assessment of the physical disabilities and psychosocial disorders in new leprosy patients admitted to a referral hospital in Belo Horizonte,

Minas Gerais, Brazil

ILC4.2-049 Family Health Strategy Digital Mapping Can Improve the Leprosy Control Program in Brazil

ILC4.2-053 Trends in Childhood Leprosy in Bangladesh

ILC4.2-056 Achievements and experiences of China’s leprosy control in more than sixty years.

ILC4.2-057 Evaluation of Cost Effectiveness of Leprosy Control Program Models in Thailand

ILC4.2-058 Reducing the Burden of Leprosy, a Challenge in Kailali District of Far West Region of Nepal

ILC4.2-059 TREND OF SMEAR POSITIVE CASES IN THE URBAN SLUMS OF MUMBAI – FIELD OBSERVATIONS

ILC4.2-063 Trend of leprosy disability among newly diagnosed patients amidst a decline in number of new cases in Southern Nigeria: a nine year review.

ILC4.2-064 The Difficult Diagnosis of Early Leprosy in Childhood

ILC4.2-065TOWARDS THE DEVELOPMENT OF A SCALE TO MEASURE THE QUALITY OF THE ACTIONS IN CONTACT-TRACING PROGRAMMES: THE

EXPERIENCE OF INTEGRAHANS SCALE USE IN THE NORTH AND NORTHEAST BRAZIL

ILC4.2-066 Analysis of Leprosy Endemic and Its Control in HeBei Province

ILC4.2-067―Early case detection through active search method Leprosy control– in underserved area of Meghalaya State – North East Indian Region- difficulties faced

analysis ‖.

ILC4.2-068 An Overview on Prevention and Control Status of Lepriasis in Guangyuan City

ILC4.2-069 The research of dynamic and countermeasures of the prevention and treatment of leprosy in Qingyang,Gansu,1949-2013

ILC4.2-071RECURRENCE OF LEPROSY CASES IN BRAZILIAN FAMILIES CIRCLES: THE OPERATIONAL ROLE OF INTRADOMICILIARY CONTACTS, RESIDENTS

CO-INHABITANTS AND SOCIALS CO-INHABITANTS IN NORTHEAST BRAZIL

Abstract No. Title


ILC4.2-072 A discussion on strategies for control of leprosy in Liangshan in the next five years

ILC4.2-073 Analysis on epidemiological characteristics of leprosy in Guangxi province from 2006 to 2015 and strategy for leprosy

ILC4.2-074 Survey on the awareness rate of leprosy control core knowledge for close contacts of leprosy in Guizhou province

ILC4.2-075 Analysis of disability status of new leprosy in Qiandongnan from 2003-2012

ILC4.2-076 Comparative study on 4 case-detection methods of leprosy in Guangxi, China

ILC4.2-077 Analysis of 6 cases of severe ammonia - phenyl - syndrome in Qiandongnan

ILC4.2-078 The mentality of how to prevent and cure leprosy in low endemic area under the new situation

ILC4.2-079 Promoting the construction of a new service system for leprosy control implemented by CDC and hospital collaboration

ILC4.2-080 The analysis of new cases of leprosy in Guizhou Province from 2011 to 2015

ILC4.2-081 Study on Control Strategies and Epidemic Characteristics of Leprosy in Qiandongnan Prefecture from 2003 to 2012

ILC4.2-082 Problems and Countermeasures on the Writing of Medicine Record　＆　Electronic Medicine Record about Leprosy in Guizhou Province

ILC4.2-083 Discussion on the prospect and evaluation the preliminary results of implementing the program of eliminating the harm of leprosy for early cases finding

ILC4.2-084 Analysis of 2 cases of misdiagnosis of leprosy

ILC4.2-085 2 cases of tuberculoid leprosy relapse

ILC4.2-086 2 cases of Paris polyphylla and other external medicine cure leprosy plantar ulcers

ILC4.2-087 The effect of the project carried out actively cases finding measures in low prevalence area of leprosy

ILC4.2-088 1 cases of treatment experience After amputation wound healing

Abstract No. Title


ILC4.2-089 institutional teen age leprosy cases -discussion on various dimension

ILC4.2-090 Analysis of epidemiological characteristics and control measures of Leprosy during 1991-2012 in Baoan ,Shenzhen city

ILC4.2-091 Introduction to the villages and towns part-time doctors of leprosy for manage and work thinking

ILC4.2-092 Assessment for the effect of leprosy suspicious symptom surveillance system in Zhejiang province

ILC4.2-093 The Role of Leprosy Suspicious Symptom Monitoring System in Early Detection

ILC4.2-095 Advances in leprosy control and research

ILC4.2-097 Burden of Disease of Leprosy Involved Patients in Zhejiang Province and Its Health Service Utilization

ILC4.2-099 Effect evaluation of Leprosy health education among floating population in Haining city

ILC4.2-100 An report on advance in leprology discipline of Jiangsu Province from 2005 to 2014

ILC4.2-101 The strategy and its effect of leprosy control after basic elimination of leprosy in Jiangsu province

ILC4.2-102 Investigation and?analysis on the current?situation of leprosy control team in Jiangsu Province

ILC4.2-103 Analysis of recurrence Leprosy cases after MDT in Yunnan in 2005--2014

ILC4.2-104 Cases analysis of newly diagnosed leprosy in Yunnan in 2009--2013

ILC4.2-105 Clinical and epidemic analysis of Children leprosy cases of Yunnan in 2008--2012

ILC4.2-106 Analysis of incidence of leprosy in families with members affected by leprosy in Wenshan City in 1999-2014

ILC4.2-107 Evaluation of the implementation of the central subsidy leprosy control projects in Yongren County

ILC4.2-108 The research of the cure effect evaluation of the leprosy MDT in Xishuangbanna prefecture

Abstract No. Title


ILC4.2-109 Leprosy prevention strategies

ILC4.2-110 Early diagnosis of and disability prevention from leprosy through enhanced contact examination in selected high endemic districts in Nepal

ILC4.2-111 Analysis of Epidemic Feature of Newly Detected Leprosy Cases from 2005 to 2014 in Sangzhi County

ILC4.2-115 A retrospective study of patient’s reported delays in leprosy diagnosis in Nepal

ILC4.3-003 Integrating leprosy post exposure prophylaxis into an existing health system: the Sri Lankan experience

ILC4.3-006 Sis-PEPHans: A Web System to Support the Application of the Post-Exposure Chemoprophylaxis Pilot Program for Leprosy in Brazil

ILC4.3-008 Skin- and nerve lesion in leprosy: an intimate risky relationship?

ILC4.3-013 Hidden leprosy cases in Tanzania found through community empowerment and Leprosy post exposure prophylaxis activities

ILC4.3-016 Global Strategy of Decreasing Delayed Diagnose and Disability for Leprosy Patient

ILC4.3-019 Chemoprophylaxis with single-dose rifampicin could provide short-term protection against PB leprosy after BCG vaccination: Protocol

ILC4.3-020 Impact assessment of the implementation of comprehensive mechanism of leprosy prevention and control

ILC4.3-021Effect of single dose rifampicin or rifapentine on prevention of leprosy in household contacts of patients with diagnosed leprosy from in southwest China: cluster

randomised controlled trial

ILC4.4-001 Active screening for close contacts of highly infectious leprosy affected persons to interrupt the transmission of leprosy

ILC4.4-002 The incidence of leprosy in Firozabad District, Uttar Pradesh (India)

ILC4.4-004 Validation of a ND-O–LID ELISA as a tool for the detection of multibacillary and paucibacillary leprosy in Colombia

ILC4.4-005 Lymph and Slit Skin Smear Samples May Help Etiologic Diagnosis of Leprosy Using Polymerase Chain Reaction with Ag85B, TTC, RLEP and MntH primers.

ILC4.4-006 Polymerase Chain Reaction Method as an early detection of Mycobacterium leprae in asymptomatic leprosy cases in leprosy endemic area of Papua-Indonesia

Abstract No. Title


ILC4.4-007 Use of cellular and serological tests in dermatology clinics to aid the differential diagnosis of leprosy from confounding presentations

ILC4.4-010 Use of a rapid test containing the ND-O-BSA and the LID-1 for the serodiagnosis of leprosy in endemic regions of Brazil

ILC4.4-011 Diagnostic, Follow Up and Household Contact of Leprosy Patients in Misiones, Argentina

ILC4.4-013 Genomic Diversity in Mycobacterium leprae Isolates from Leprosy Cases in South India; Genotyping of Strain Specific Single Nucleotide Polymorphisms.

ILC4.4-015 Utility of recombinant proteins to detect leprosy patients lacking antibodies against PGL-I

ILC4.4-016 Molecular Evidence for the Aerial Route of Infection of Mycobacterium leprae and the Role of Asymptomatic Carriers in the Persistence of Leprosy

ILC4.4-017 Skin Smear Positive among New Leprosy Patients from Allahabad District Attending a Referral Hospital in Northern India

ILC4.4-018 Clinical and Serological Analysis in Long-term Follow-up of Household Contacts of Leprosy Patients.

ILC4.4-019 M. leprae DNA detection by qPCR in Skin Smears of Oligosymptomatic and Asymptomatic Contacts with Subclinical Infection Revealed by anti-PGL-1 ELISA.

ILC4.4-020 Electromyography and Peripheral Nerve Biopsy in Asymptomatic Leprosy Contacts: a New Strategy for Early Diagnosis

ILC4.4-021Spatio-Temporal Epidemiology of Mycobacterium leprae Infection among Leprosy Patients and Household Contacts through Geographic Information Systems

Analysis of an Endemic Region in Southeast Brazil

ILC4.4-022 Multiple Correspondence Analysis for Characterization of Cytokines in Patients with Leprosy and their Household Contacts

ILC4.5-001 Business Intelligence (BI) to verify and validate the indicators of the Leprosy elimination as a public health problem in MDG Target 6 in Brazil

ILC4.5-002 EFFECTIVENESS OF INTEGRATED NTD CASE FINDING AND DISABILITY MANAGEMENT: A PILOT PROJECT IN ZAMFARA STATE, NIGERIA

ILC4.5-009 Cutaneous Leishmaniasis Misdiagnosed as Borderline Tuberculoid Leprosy: A Case Report

ILC4.5-012 Comparison Between Two Ways To Recruit The Leprosy Household Contacts: From Index Cases And From Anti-PGL1 Serology

ILC5.1-001 Leprous Neuropathy Screening: Field Testing of Sensory Testing Devices in Ecuador

Abstract No. Title


ILC5.1-003 Early detection of neuropathy in leprosy: A comparison of five new tests in field settings

ILC5.1-004 Early diagnosis of sub clinical nerve damage in leprosy

ILC5.1-006A retrospective analysis of incidence, risk factors and outcome of steroid therapy among 244 MB leprosy cases developed new disability during and after WHO-

MDT in 10 districts of Maharashtra

ILC5.1-007 Disability in People Released from Leprosy Treatment in Nigeria: Burden and Associated Factors

ILC5.1-008 Borderline Leprosy Leading to Neural Injury and Amputation in a Liver Transplant Patient: A Case Report

ILC5.1-011 Ninjurin 1 Gene D110A Single Nucleotide Polymorphism as a Genetic Marker for Nerve Damage Leprosy Patients from South India

ILC5.1-012 Deficit in Postural Balance of Individuals with Leprosy, Compared to Healthy Subjects

ILC5.1-015 An overview of monofilaments (MF) for tactile touch testing in leprosy. *Samples of all 6 loose MF available*

ILC5.1-016The Comparison of MFT and VMT between Prednisolone 32 weeks and 20 weeks in Early Neuropathy of Leprosy Patient (Randomized Controlled Trial in East

Java, Indonesia)

ILC5.2-001 People Living with Diabetes and Leprosy-related Disability in Bangladesh

ILC5.2-002 Prediction of the Occurrence of Leprosy Reactions Based on Bayesian Networks

ILC5.2-004 A comparison between FAIRMED’s two Prevention of Impairment and Deformity (POID) intervention models in India

ILC5.2-005 MH-POID PROJECT:FAIRMED’s enhanced model towards preventing disability

ILC5.2-007 Effective Utilisation of Residual Muscle Power in Leprotic Hand- Leprotic Hand Rehabilitation Clinic.

ILC5.2-011 The problem of Leprosy deformities in Sri Lankan children

ILC5.2-013 MH-POID PROJECT: FAIRMED’s (FM) block coordinators (BC’s) a catalyst in preventing disability

ILC5.2-015 Risk Factors for Physical Disability at Release from Multi-Drug Therapy in New Cases of Leprosy at a Referral Center in Belo Horizonte, Minas Gerais - Brazil

Abstract No. Title


ILC5.2-018 ―Impact study of Protective footwear with Podiatry appliances secondary referral centre in Bihar and Jharkhand‖

ILC5.2-019Sustainable Prevention of Disability (SPOD) Services within integrated General Health Services in Coimbatore District of Tamil Nadu- Replication of Salem

Model

ILC5.2-022 Leprosy in the Metropolis: The dignity and quality of life of people affected by leprosy should be retaining

ILC5.2-024 Disability aid compliance in persons affected by Leprosy in urban and rural Maharashtra, India – a need for comprehensive study.

ILC5.2-025 Footwear for people with anesthetic feet: are options available?

ILC5.2-034 3 Dimensional printed , customized protective foot wear : An innovative and effective tool for disability prevention and social acceptance.

ILC5.2-036 Adoption of New Criteria to define the degree on physical incapacity: new experience in Brazil.

ILC5.2-038 Cost and specialized service procedures for leprosy carried out by public health services in Brazil , 2013 and 2014.

ILC5.2-041 Nepal 2015 Earthquakes: Medical response and impact in trauma-related disability prevention by a tertiary leprosy hospital during a national disaster

ILC5.2-042 Analysis of development of new disability after MDT among reported cases in State of Assam, India

ILC5.2-045OUTCOME AND IMPACT OF DISABILITY CARE SERVICES - FIELD OBSERVATIONS IN RURAL AREAS OF THANE DISTRICT, MAHARASHTRA STATE,

INDIA

ILC5.2-046 The analysis of the disability situation among new leprosy cases in Dazhou, Sichuan

ILC5.2-047 ―mPOD - Mobile Prevention of Disabilities; delivering relevant knowledge and treatment in an effective and efficient model‖

ILC5.2-048 Analysis on the disability distribution of survivals cured from leprosy in Guangxi province

ILC5.2-049 Physical disability and its repercussion in social and functional patients with leprosy post-discharge from multidrug therapy

ILC5.2-050 The impact of self-care group mode on people affected by leprosy self-care ability and Psychological behavior

ILC5.2-052 Self-Management Support for Prevention and Care of Neuropathic Feet in Low Resource Settings, a Review

Abstract No. Title


ILC5.2-054 Influences of the delay detection of leper on disabilities

ILC5.2-055 DPMR ACTIVITIES-CHENNAI'S EXPERIENCE

ILC5.3-001 Reconstructive Surgery in Hansen Disease: Nigeria Story

ILC5.3-002PUBLIC HEALTH SERVICE WHICH APPLYING HUMAN DIGNITY AND EQUAL RIGHTS for Person Affected by Leprosy,their Family and Community-in

Several Areas in Indonesia

ILC5.3-004 Effectiveness of Treadmill Gait Training in Rehabilitation after Surgical Correction of Foot drop

ILC5.3-007 ―Samutthan‖ ………equal Development for all, an initiative by State Forum (Forum of Disabled person due to leprosy) in Bihar, India

ILC5.3-008 Outcome of morbidity management in elephantiasis (lymphatic filariasis) in five districts of Bihar, India

ILC5.3-010 Physiotherapy needs of Persons affected by leprosy: trends of last five years

ILC5.3-015 Reasons of precariousness among leprosy patients and how to set rehabilitation approaches in Burundi

ILC5.3-016 Undesirable results following tendon transfer surgery for ulnar paralysis

ILC5.3-023 Non-optimal utilization of the assistive devices (wheel chair) by person affected by leprosy living in various leprosy colonies of Delhi

ILC5.3-026 P-Scale and SALSA Scale to Determine Baseline Values of Restriction In Participation And Activity Among Patients With Claw Hand Due To Leprosy

ILC5.3-027 Promoting RCS at Government Secondary Centres by LEPRA Society: Experience from Odisha (India)

ILC5.3-034 Expressed Needs of Persons Affected by Leprosy in Some Leprosy Settlements in Southern Nigeria: A Rapid Appraisal.

ILC5.3-035 Community Intervention Program for Leprosy affected Beneficiaries in Post Integration Era

ILC5.3-036 ASSSISTIVE TECHNOLOGY FOR THE RESCUE OF AUTONOMY IN LEPROSY PATIENTS WITH DISABILITIES

ILC5.3-038 Effect of clinical and nursing pathway in leprosy plantar ulcer treatment

Abstract No. Title


ILC5.3-041 Factors analysis on self-care behavior habituation of disability lepers

ILC5.3-042 Lepromatous leprosy quality of life investigate in Shaanxi Province

ILC5.3-045 Effect of Mobile Therapy team for People Affected by Leprosy in flood affected areas in Sothern India

ILC5.3-046 Development of Adaptive device kit to improve quality of life for persons affected by leprosy

ILC5.3-047 Selection criteria for splints / Orthosis in leprosy

poster presentation list for ilc2016 - ciccstciccst.org.cn/ilc2016/poster.pdf · abstract no. title...

Documents